Reporting randomized, controlled trials of herbal interventions: An elaborated CONSORT statement

被引:393
作者
Gagnier, JJ
Boon, H
Rochon, P
Moher, D
Barnes, J
Bombardier, C
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] Inst Evaluat Sci, Toronto, ON, Canada
[3] Inst Work & Hlth, Toronto, ON, Canada
[4] Toronto Gen Res Inst, Toronto, ON, Canada
[5] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada
[6] Univ London, London, England
关键词
D O I
10.7326/0003-4819-144-5-200603070-00013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Herbal medicinal products are widely used, vary greatly in content and quality, and are actively tested in randomized, controlled trials (RCTs). The authors' objective was to develop recommendations for reporting RCTs of herbal medicine interventions, based on the need to elaborate on the 22-item CONSORT (Consolidated Standards of Reporting Trials) checklist. Telephone calls were made and a consensus meeting was held with 16 participants in Toronto, Canada, to develop these recommendations. The group agreed on context-specific elaborations of 9 CONSORT checklist items for RCTs of herbal medicines. Item 4, concerning the herbal medicine intervention, required the most extensive elaboration. These recommendations have been developed to improve the reporting of RCTs using herbal medicine interventions.
引用
收藏
页码:364 / 367
页数:4
相关论文
共 22 条
[1]  
Carlson M, 1998, J AOAC INT, V81, P691
[2]  
DREW S, 2001, BMJ-BRIT MED J, V321, P1
[3]  
Dubber MJ, 2004, J PHARM PHARM SCI, V7, P303
[4]  
GAGNIER JJ, 2006, IN PRESS J CLIN EPID
[5]  
GROENEWEGEN WA, 1986, LANCET, V1, P44
[6]   Content versus label claims in ephedra-containing dietary supplements [J].
Gurley, BJ ;
Gardner, SF ;
Hubbard, MA .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (10) :963-969
[7]   Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements [J].
Haller, CA ;
Duan, MJ ;
Benowitz, NL ;
Jacob, P .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2004, 28 (03) :145-151
[8]  
Harkey M. R., 2002, AM J CLIN NUTR, V75, P600
[9]   PARTHENOLIDE CONTENT AND BIOACTIVITY OF FEVERFEW (TANACETUM-PARTHENIUM (L) SCHULTZ-BIP) - ESTIMATION OF COMMERCIAL AND AUTHENTICATED FEVERFEW PRODUCTS [J].
HEPTINSTALL, S ;
AWANG, DVC ;
DAWSON, BA ;
KINDACK, D ;
KNIGHT, DW ;
MAY, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (05) :391-395
[10]   For randomized controlled trials, the quality of reports of complementary and alternative medicine was as good as reports of conventional medicine [J].
Klassen, TP ;
Pham, B ;
Lawson, ML ;
Moher, D .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2005, 58 (08) :763-768